- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07682597
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
26. juni 2026 opdateret af: Timothy Mullett
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based
This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV).
The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities.
Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state.
The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns.
The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners.
The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
200
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Joseph Alexander, MD
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
Studiesteder
-
-
Mississippi
-
Greenville, Mississippi, Forenede Stater, 38703
- Rekruttering
- Delta Health System
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 859-323-0892
- E-mail: joseph.alexander@uky.edu
-
Greenwood, Mississippi, Forenede Stater, 38930
- Rekruttering
- Greenwood Leflore Hospital
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Gulfport, Mississippi, Forenede Stater, 39501
- Rekruttering
- Memorial Hospital Gulfport
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Hattiesburg, Mississippi, Forenede Stater, 39401
- Rekruttering
- Hattiesburg Clinic
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 859-323-0892
- E-mail: joseph.alexander@uky.edu
-
Jackson, Mississippi, Forenede Stater, 39216
- Rekruttering
- University of Mississippi Medical Center
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
New Albany, Mississippi, Forenede Stater, 38652
- Rekruttering
- Baptist Memorial Hospital
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Tupelo, Mississippi, Forenede Stater, 38801
- Rekruttering
- North Mississippi Health Services
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
-
Nevada
-
Hawthorne, Nevada, Forenede Stater, 89415
- Rekruttering
- Mt. Grant General Hospital
-
Kontakt:
- Jospeh Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Pahrump, Nevada, Forenede Stater, 89048
- Rekruttering
- Desert View Hospital
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Reno, Nevada, Forenede Stater, 89502
- Rekruttering
- Renown Regional Medical Center
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Reno, Nevada, Forenede Stater, 89511
- Rekruttering
- Sierra Medical Center
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Winchester, Nevada, Forenede Stater, 89109
- Rekruttering
- Sunrise Health
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
Winnemucca, Nevada, Forenede Stater, 89445
- Rekruttering
- Humboldt General Hospital
-
Kontakt:
- Joseph Alexander
- Telefonnummer: 8593230892
- E-mail: joseph.alexander@uky.edu
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Member of a state-based lung cancer screening implementation team in Mississippi or Nevada.
- Leadership member of the Mississippi state team or Nevada state team
- Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC)
- Willing to participate in study-related assessments an implementation activities
Exclusion Criteria:
- None
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Screening
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Health Services Research (SBI Intervention)
Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.
|
Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Statewide Capacity Assessment Scores for Lung Cancer Screening Implementation and Sustainability Capacity
Tidsramme: Up to 3 Years
|
Statewide capacity will be assessed using the State Team Assessment (STA) and Coalition Assessment (CA) instruments.
Higher scores indicate greater capacity to implement an sustain lung cancer screening activities.
|
Up to 3 Years
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. marts 2026
Primær færdiggørelse (Anslået)
1. juli 2028
Studieafslutning (Anslået)
1. juli 2029
Datoer for studieregistrering
Først indsendt
26. juni 2026
Først indsendt, der opfyldte QC-kriterier
26. juni 2026
Først opslået (Faktiske)
6. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
6. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
26. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- MCC-25-KYQUILS-NVMS
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Lungekræftscreening
-
Seoul National University HospitalAfsluttet
-
Seoul National University HospitalAfsluttet
-
Chinese Chronic Respiratory Disease Research NetworkRekruttering
-
Mansoura UniversityAfsluttetOne Lung VentilationEgypten
-
Dokuz Eylul UniversityAfsluttetOne Lung VentilationKalkun
-
Yonsei UniversityAfsluttetOne Lung VentilationKorea, Republikken
-
Sichuan UniversityWest China HospitalMidlertidigt ikke tilgængeligOne Lung Ventilation
-
Luca BrazziA.O.U. Città della Salute e della Scienza - Molinette HospitalIkke rekrutterer endnuIntubationskomplikation | One Lung Ventilation
-
Ankara Ataturk Sanatorium Training and Research...Ikke rekrutterer endnuOne-lung Ventilation (OLV)Tyrkiet (Türkiye)
-
Joseph D. TobiasAfsluttetOne-lung Ventilation (OLV)Forenede Stater
Kliniske forsøg med QUILS SBI Intervention
-
The National Center on Addiction and Substance...National Institute on Drug Abuse (NIDA)Afsluttet
-
Jennifer Bogner, PhD, ABPPU.S. Department of EducationAfsluttetTraumatisk hjerneskadeForenede Stater
-
The National Center on Addiction and Substance...National Institute on Drug Abuse (NIDA)Ikke rekrutterer endnu
-
PfizerEmergent Product Development Seattle LLCAfsluttetRheumatoid arthritisForenede Stater, Canada
-
PfizerEmergent Product Development Seattle LLCAfsluttet
-
PfizerEmergent Product Development Seattle LLCAfsluttetLupus erythematosus, systemiskForenede Stater
-
Sentien Biotechnologies, Inc.Aktiv, ikke rekrutterendeCOVID-19 | Sepsis | Akut nyreskadeForenede Stater
-
Sentien Biotechnologies, Inc.Aktiv, ikke rekrutterendeAkut nyreskadeForenede Stater
-
Skye Bioscience, Inc.AfsluttetPrimær åbenvinkelglaukom | Okulær hypertensionForenede Stater
-
Steno Diabetes Center CopenhagenRekrutteringNyre sygdom | Diabetes type 2Danmark